These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15064164)

  • 61. Criteria for analyzing interactions between biologically active agents.
    Berenbaum MC
    Adv Cancer Res; 1981; 35():269-335. PubMed ID: 7041539
    [No Abstract]   [Full Text] [Related]  

  • 62. Carcinogenesis by combinations of N-nitroso compounds in rats.
    Lijinsky W; Reuber MD; Riggs CW
    Food Chem Toxicol; 1983 Oct; 21(5):601-5. PubMed ID: 6686188
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The development of carcinoma in liver of rats treated with m-toluylenediamine and the synergistic and antagonistic effects with other chemicals.
    Ito N; Hiasa Y; Konishi Y; Marugami M
    Cancer Res; 1969 May; 29(5):1137-45. PubMed ID: 5781104
    [No Abstract]   [Full Text] [Related]  

  • 64. The relationship between nuclear receptor-estrogen binding and uterotrophic responses.
    Anderson JN; Clark JH; Peck EJ
    Biochem Biophys Res Commun; 1972 Sep; 48(6):1460-8. PubMed ID: 5077831
    [No Abstract]   [Full Text] [Related]  

  • 65. Potent mutagenicity to Salmonella of an equimolar mixture of 52 chemicals used in five collaborative studies.
    Ashby J; Paton D; Callander RD
    Mutagenesis; 1988 Jul; 3(4):345-7. PubMed ID: 3062324
    [No Abstract]   [Full Text] [Related]  

  • 66. Combination effects of forty carcinogens administered at low doses to male rats.
    Takayama S; Hasegawa H; Ohgaki H
    Jpn J Cancer Res; 1989 Aug; 80(8):732-6. PubMed ID: 2511179
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genetic activity profiles--application in assessing potential carcinogenicity of complex environmental mixtures.
    Waters MD; Claxton LD; Stack HF; Graedel TE
    IARC Sci Publ; 1990; (104):75-88. PubMed ID: 2228145
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Carcinogenic mixtures.
    Krewski D; Thomas RD
    Risk Anal; 1992 Mar; 12(1):105-13. PubMed ID: 1574610
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Toxic equivalency factors (TEFs) for polycyclic aromatic hydrocarbons (PAHs).
    Nisbet IC; LaGoy PK
    Regul Toxicol Pharmacol; 1992 Dec; 16(3):290-300. PubMed ID: 1293646
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The use of the Salmonella/microsomal assay to determine mutagenicity in paired chemical mixtures.
    Salamone MF; Heddle JA; Katz M
    Can J Genet Cytol; 1979 Mar; 21(1):101-7. PubMed ID: 476531
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Temporal relationships between hormone receptor binding and biological responses in the uterus: studies with short- and long-acting derivatives of estriol.
    Lan NC; Katzenellenbogen BS
    Endocrinology; 1976 Jan; 98(1):220-7. PubMed ID: 174891
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Estrogen-induced uterine responses and growth: relationship to receptor estrogen binding by uterine nuclei.
    Anderson JN; Peck EJ; Clark JH
    Endocrinology; 1975 Jan; 96(1):160-7. PubMed ID: 162876
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sensitivity of the immature rat uterotrophic assay to mixtures of estrogens.
    Tinwell H; Ashby J
    Environ Health Perspect; 2004 Apr; 112(5):575-82. PubMed ID: 15064164
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for Economic Co-operation and Development.
    Owens JW; Ashby J
    Crit Rev Toxicol; 2002; 32(6):445-520. PubMed ID: 12487363
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Curated Database of Rodent Uterotrophic Bioactivity.
    Kleinstreuer NC; Ceger PC; Allen DG; Strickland J; Chang X; Hamm JT; Casey WM
    Environ Health Perspect; 2016 May; 124(5):556-62. PubMed ID: 26431337
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increasing the sensitivity of the rodent uterotrophic assay to estrogens, with particular reference to bisphenol A.
    Ashby J
    Environ Health Perspect; 2001 Nov; 109(11):1091-4. PubMed ID: 11712991
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative assessment of endocrine modulators with oestrogenic activity: I. Definition of a hygiene-based margin of safety (HBMOS) for xeno-oestrogens against the background of European developments.
    Bolt HM; Janning P; Michna H; Degen GH
    Arch Toxicol; 2001 Jan; 74(11):649-62. PubMed ID: 11218041
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Scientific issues associated with the validation of in vitro and in vivo methods for assessing endocrine disrupting chemicals.
    Ashby J
    Toxicology; 2002 Dec; 181-182():389-97. PubMed ID: 12505341
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The leading role and responsibility of the international scientific community in test development.
    Ashby J
    Toxicol Lett; 2003 Apr; 140-141():37-42. PubMed ID: 12676449
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Non-genomic effects of xenoestrogen mixtures.
    Viñas R; Jeng YJ; Watson CS
    Int J Environ Res Public Health; 2012 Aug; 9(8):2694-714. PubMed ID: 23066391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.